
Trileptal Film-coated Tablets 150 mg (Oxcarbazepine)
150mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Oxcarbazepine is an anticonvulsant ingredient that helps control seizure activity.
MFDS ingredient code M086765
Oxcarbazepine is a medication belonging to the anticonvulsant class, primarily used for the treatment of seizures. It aims to prevent seizures by suppressing excessive electrical activity in the nervous system.
Oxcarbazepine reduces the excessive transmission of nerve signals by blocking sodium channels in brain neurons. This alleviates the state of hyperexcitability in the nervous system, thereby suppressing seizures.
Approved uses differ by product. Check each product's information for its actual use.
Oxcarbazepine is structurally similar to carbamazepine but has relatively fewer side effects and drug interactions. Additionally, its metabolic pathway differs, resulting in a somewhat different impact on liver function.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
11 total

150mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

300mg
Tablet · Prescription medication
Korea Novartis Co., Ltd.

600mg
Tablet · Prescription medication
Korea Novartis Co., Ltd.

300mg
Tablet · Prescription medication
Unimeds Pharmaceuticals Co., Ltd.
6g
Suspension · Prescription medication
Korea Novartis Co., Ltd.

300mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.

150mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

600mg
Tablet · Prescription medication
Myeongin Pharmaceutical Co., Ltd.
Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.